| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $210.8M | +47.6% |
| SG&A Expense | $31.4M | +11.3% |
| Operating Income | -$242.2M | -41.6% |
| Net Income | -$235.9M | -40.4% |
| EPS (Basic) | -$3.95 | -22.3% |
| EPS (Diluted) | -$3.95 | -22.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.6M | -29.3% |
| Current Assets | $129.4M | -51.3% |
| Total Assets | $165.1M | -46.1% |
| Current Liabilities | $51.1M | +81.9% |
| Total Liabilities | $73.8M | +36.7% |
| Stockholders' Equity | $91.3M | -63.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$188.2M | -22.5% |
| Capital Expenditures | $729K | -76.2% |
| Investing Cash Flow | $83.3M | -4.5% |
| Financing Cash Flow | $54.3M | +45.3% |
| Free Cash Flow | -$188.9M | -20.5% |